Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children

De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial extracts in rats. Life Sci 28:89–94

Dillon MJ, Gillin ME, Ryness JM, de Swiet M (1976) Plasma renin activity and aldosterone concentration in the human newborn. Arch Dis Child 51:537–540

Downie PF, Talwar S, Squire IB, Davies JE, Barnett DB, NG LL (1999) Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clinical Science 97:255–258

Feller SM, Gagelmann M, Forssmann WG (1989) Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci 10:93–94

Fiselier TJW, Lijnen P, Monnens L, van Munster P, Jansen M, Peer P (1983) Levels of renin, angiotensin I and II angiotensin-converting enzyme and aldosterone in infancy and childhood. Eur J Pediatr 141:3–7

Gemelli M, Mami C, DeLuca F, Stelitano L, Bonaccorsi P, Martino F (1991) Atrial natriuretic peptide and reninaldosterone relationship in healthy newborn infants. Acta Paediatr Scand 80:1128–1133

Herrmann M, Scharhag J,MicleaM, Urhausen A, Herrmann W, Kindermann W (2003) Post race kinetics of cardiac troponin T and I and N-terminal pro brain natriuretic peptide in marathon runners. Clin Chem 5:831–834

Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE (2002) Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community population. BMJ 324:1498–1503

Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C (1993) Renal, endocrine and haemodynamic effects of human brain natriuretic peptide in normal men. J Clin Endocrinol Metab 76:91–96

Hong M, Yan Q, Tao B, Boersma A, Han KK, Vantyghem MC, Racadot A, Lefebvre J (1992) Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats. Biol Chem Hoppe Seyler 373:213–218

Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner ER (1997) Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrin 47:287–296

Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA (1995) The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) ciculates in plasma. Biochem Biophys Res Commun 214:1175–1183

Koch A, Singer H (2003) Normal values of B-type natriuretic peptid in infants, children, and adolescents. Heart 89:875–878

Krüger C, Rauh M, Doerr HG (1998) Immunoreactive renin concentrations in healthy children from birth to adolescence. Clin Chim Acta 274:15–17

Luchner A, Holmer S, Schunkert H, Rieger GA (2003) Clinical utility of biochemical markers of heart failure (Bedeutung der Herzinsuffizienzmarker BNP und NT-proBNP für die Klinik) Dtsch Ärztebl 100:B2757–2763

McCullough PA, Omland T, Maisel AS (2003) B-type natriuretic peptides: A diagnostic breakthrough for clinicians. Reviews Cardiovasc Med 4:72–80

Meyer T, Schwaab B, Görge G, Scharhag J, Herrmann M, Kindermann W (2004) Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure? Z Kardiol 93:540–545

Mir T, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, Laer S, Weil J (2003) Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatr 112:896–899

Mir TS, Marohn S, Läer S, Eiselt M, Grollmus O, Weil J (2002) Plasma concentrations of N-terminal pro brain natriuretic peptide (N-BNP) in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatr 110:1243

Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogowa Y, Shirakami G, Jougasaki M, Obata K,Yasue H, Kambayashi Y, Inouye K, Imura H (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402–1412

Nir A, Bar-Oz B, Brooks R, Korach A, Rein AJJT (2004) N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 93:603–607

Peacock WJ (2002) The B-type natriuretic peptide assay: A rapid test for heart failure. Cleveland Clin J Med 69:243–251

Rauh M, Koch A (2003) Plasma N-Terminal Pro-B-Type natriuretic peptide concentrations in control population of infants and children. Clin Chem 49:1563–1564

Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, PedersenF (2003) The influence of age and sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89:745–751

Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW (1998) Plasma N-terminal probrain natriuretic peptide and adrenomedullin: new neuro-hormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97:1921–1929

Schweitz H, Vigne P, Moinier D, Frelin C, Lazdunski M (1992) A new member of the natriuretic peptide family is present in the venom of the Green Mamba (Dendroaspis angusticeps). J Biol Chem 267:13928–13032

Sudoh T, Kangawa K, Minamino N, Matsuo H (1988) A new natriuretic peptide in porcine brain. Nature 332:78–81

Sudoh T, Minamino N, Kangawa K, Matsuo H (1990) C-type natriuretic peptide: a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168:863–870

Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000) Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126–1130

Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, Ohnishi M, Sawaki M, Fujii M, Horie H, Sugimoto Y, Kinoshita M (1999) Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with symptomatic left ventricular dysfunction. Comparison with plasma angiotensin ll and endothelin-1. Eur Heart J 20:1799–1807